von Beck, T.; Mena Hernandez, L.; Zhou, H.; Floyd, K.; Suthar, M.S.; Skolnick, J.; Jacob, J.
Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. Viruses 2023, 15, 1841.
https://doi.org/10.3390/v15091841
AMA Style
von Beck T, Mena Hernandez L, Zhou H, Floyd K, Suthar MS, Skolnick J, Jacob J.
Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. Viruses. 2023; 15(9):1841.
https://doi.org/10.3390/v15091841
Chicago/Turabian Style
von Beck, Troy, Luis Mena Hernandez, Hongyi Zhou, Katharine Floyd, Mehul S. Suthar, Jeffrey Skolnick, and Joshy Jacob.
2023. "Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo" Viruses 15, no. 9: 1841.
https://doi.org/10.3390/v15091841
APA Style
von Beck, T., Mena Hernandez, L., Zhou, H., Floyd, K., Suthar, M. S., Skolnick, J., & Jacob, J.
(2023). Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. Viruses, 15(9), 1841.
https://doi.org/10.3390/v15091841